+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sarepta Therapeutics - logo

Sarepta Therapeutics is a biopharmaceutical company that focuses on the development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD). It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

From
From
From
From
Translational Regenerative Medicine Market Report 2024-2034 - Product Thumbnail Image

Translational Regenerative Medicine Market Report 2024-2034

  • Report
  • February 2024
  • 270 Pages
  • Global
From
From
RNA Based Therapeutics and Vaccines Market Report 2022-2032 - Product Thumbnail Image

RNA Based Therapeutics and Vaccines Market Report 2022-2032

  • Report
  • October 2022
  • 213 Pages
  • Global
From
Fertility Drugs Market Report 2026 - Product Thumbnail Image

Fertility Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Regenerative Medicine Market Report 2023-2033 - Product Thumbnail Image

Regenerative Medicine Market Report 2023-2033

  • Report
  • March 2023
  • 232 Pages
  • Global
From
From
From
Fanconi Anemia Treatment Market - Global Forecast to 2030 - Product Thumbnail Image

Fanconi Anemia Treatment Market - Global Forecast to 2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
Alpha Mannosidosis Market - Global Forecast 2026-2032 - Product Thumbnail Image

Alpha Mannosidosis Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 182 Pages
  • Global
From
Loading Indicator